InfuSystem Holdings, Inc (INFU) stock
Close on Nov 13, 2026Market cap $293.18MP/E 32.7Yield –
InfuSystem Holdings, Inc grew revenue 2.4% to $144.44M over the twelve months to Sep 30, 2026. Operating income rose 31.2% to $14.20M, moving the operating margin from 7.7% to 9.8%. Free cash flow was $24.76M, up 2.1% from a year earlier. At the latest close the market valued the company at $293.18M, 32.7 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $293.18M
- P/E ratio
- 32.7
- Price to sales
- 2.03
- Price to book
- 4.57
- Dividend yield
- –
- Free cash flow yield
- 8.45%
Fundamentals
- Revenue
- $144.44M
- Net income
- $9.44M
- EPS, diluted
- $0.45
- Free cash flow
- $24.76M
- Book value per share
- $3.04
- Diluted shares
- 21M
Trading
- Next earnings
- Feb 23, 2027 (estimated, before the open)
- Previous close
- $14.79
- Open
- $14.77
- Day's range
- $14.67 – $15.06
- Volume
- 144,991
- Average volume (20 days)
- 155,532
- Index membership
- Russell 2000 (since Jun 2026)
- Beta (5 years)
- 1.18
- 52-week range
- $7.29 – $15.47
- RSI (14 days)
- 59.3
- Volatility (1 year)
- 57.0%
- Relative volume
- 1.03×
- WACC
- 10.6%
Index membership is inferred from the holdings of funds that track each index (IWM), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | INFU | S&P 500 | Difference | INFU per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +9.1% | -3.0% | +12.2 pts | ||
| 3 months | +17.9% | -2.8% | +20.7 pts | ||
| Year to date | +64.1% | +11.5% | +52.6 pts | ||
| 1 year | +44.9% | +13.5% | +31.4 pts | ||
| 3 years | +67.3% | +77.7% | −10.4 pts | +18.7% | +21.1% |
| 5 years | -7.7% | +72.6% | −80.3 pts | -1.6% | +11.5% |
| 10 years | +674.7% | +308.2% | +366.6 pts | +22.7% | +15.1% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases InfuSystem filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Results
- Update
- Update
- Update
- Update
About InfuSystem
Surgical & Medical Instruments & Apparatus
InfuSystem Holdings, Inc. operates as a healthcare service provider facilitating outpatient care for durable medical equipment manufacturers and healthcare providers. The company provides ambulatory infusion pumps, negative pressure wound therapy devices, related disposable supplies, and biomedical services, including inspection, repair, and certification. Business activities are organized into two operational segments: Patient Services and Device Solutions. Patient Services focuses on clinic-to-home healthcare delivery, continuous chemotherapy infusion, pain management, and wound care, accompanied by third-party billing and clinical support. Device Solutions provides equipment sales, rentals, consumable distribution, and direct biomedical maintenance services to clinical practices. InfuSystem serves hospitals, oncology practices, ambulatory surgery centers, infusion clinics, home care providers, skilled nursing facilities, and acute care facilities.
Company profile, executives and historyInfuSystem stock: common questions
What is InfuSystem's stock price?
INFU closed at $14.72 on Nov 13, 2026, down 0.47% on the day. Over the past 52 weeks it traded between $7.29 and $15.47.
What is InfuSystem's market cap?
InfuSystem was worth $293.18M at the close on Nov 13, 2026: the share price times the diluted shares outstanding.
What is INFU's P/E ratio?
INFU trades at 32.7 times earnings, based on diluted earnings per share of $0.45 over the twelve months to Sep 30, 2026.
How much revenue does InfuSystem make?
InfuSystem reported revenue of $144.44M for the twelve months to Sep 30, 2026, up 2.4% from a year earlier.
Does InfuSystem pay a dividend?
No. InfuSystem has not paid a cash dividend over the last twelve months.
When does InfuSystem report earnings next?
InfuSystem is expected to report Q4 FY2026 results on Feb 23, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has INFU stock performed over the past year?
Including dividends, INFU returned +44.9% over the past year, against +13.5% for the S&P 500.
How many INFU shares are sold short?
1M shares were sold short at the latest FINRA report, 3.91% of the float, or 5.7 days of average trading volume.
Who are InfuSystem's competitors?
Companies most similar to InfuSystem by business, industry and size include DCTH, IRMD, ANGO, KRMD, STIM.
See a number that looks wrong?